Recent developments in the research on biomarkers of cholangiocarcinoma in primary sclerosing cholangitis
Primary sclerosing cholangitis (PSC) is characterized by a chronic inflammatory process of the bile ducts of unclear aetiology. It is often complicated by cholangiocarcinoma (CCA) with a dismal prognosis. Early detection of CCA is important because treatment options for advanced disease are limited....
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Article (Journal) |
| Lingua: | inglese |
| Pubblicazione: |
2019
|
| In: |
Clinics and research in hepatology and gastroenterology
Year: 2019, Volume: 43, Fascicolo: 3, Pages: 236-243 |
| ISSN: | 2210-741X |
| DOI: | 10.1016/j.clinre.2018.08.013 |
| Accesso online: | Verlag, Volltext: http://dx.doi.org/10.1016/j.clinre.2018.08.013
|
| Note sull'autore: | Andreas Wannhoff, Daniel N. Gotthardt |
| Riassunto: | Primary sclerosing cholangitis (PSC) is characterized by a chronic inflammatory process of the bile ducts of unclear aetiology. It is often complicated by cholangiocarcinoma (CCA) with a dismal prognosis. Early detection of CCA is important because treatment options for advanced disease are limited. Besides the established markers, like CA19-9, recent developments have been made using latest technologies. This review summarizes the recent advances and remaining limitations of biomarkers of CCA in PSC. |
|---|---|
| Descrizione del documento: | Available online 25 September 2018 Gesehen am 24.06.2019 |
| Descrizione fisica: | Online Resource |
| ISSN: | 2210-741X |
| DOI: | 10.1016/j.clinre.2018.08.013 |